Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma

Table 2

Clinicopathologic features at presentation and follow-up data.

Case	Age	Tumor size (mm)	Multifocality (number of tumors)	Lymphovascular invasion	Metastases	Follow-up
1	59	30	No	No	Bone	Local relapse after 2 years; died of disease after 36 months
2	77	35; 5	Yes (2)	Yes	Axillary lymph nodes	Disease free after 3 years and then lost to follow-up
3	83	27	No	No	Axillary lymph nodes	Disease free after 3 months and then lost to follow-up
4	85	35; 7; 5	Yes (3)	Yes	Axillary lymph nodes	Skin metastases after 4 months; died of disease after 15 months